Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AXONAL DEGENERATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | AXONAL DEGENERATION |
| Key Genes/Proteins | FGF2, GFAP, HDAC6, MLKL |
| Related Diseases | ALS, DEMENTIA, EXCITOTOXICITY, GLUTAMATE, INFLAMMATION |
| Related Pathways | DNA DAMAGE RESPONSE |
Knowledge base pages for this entity
graph TD
AXONAL_DEGENERATION["AXONAL DEGENERATION"]
AXONAL_DEGENERATION -->|"contributes to"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
AXONAL_DEGENERATION -->|"involved_in"| Multiple_Sclerosis["Multiple Sclerosis"]
RIPK1["RIPK1"] -->|"mediates"| AXONAL_DEGENERATION
DRP1["DRP1"] -->|"mediates"| AXONAL_DEGENERATION
Mitochondrial_Defects["Mitochondrial Defects"] -->|"causes"| AXONAL_DEGENERATION
RIPK3["RIPK3"] -->|"mediates"| AXONAL_DEGENERATION
OPTN["OPTN"] -.protects against.-> AXONAL_DEGENERATION
Multiple_Sclerosis -->|"causes"| AXONAL_DEGENERATION
Mitochondrial_Dysfunction["Mitochondrial Dysfunction"] -->|"contributes to"| AXONAL_DEGENERATION
Necroptosis["Necroptosis"] -->|"causes"| AXONAL_DEGENERATION| Target | Relation | Type | Str |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis | contributes_to | disease | 0.92 |
| Multiple Sclerosis | involved_in | disease | 0.90 |
| Hereditary Polyneuropathy | mediates | disease | 0.80 |
| Regulated Cell Death | associated_with | process | 0.75 |
| GLUTAMATE | activates | phenotype | 0.65 |
| TAU | interacts_with | protein | 0.65 |
| NEURODEGENERATION | protects_against | disease | 0.65 |
| NECROPTOSIS | regulates | phenotype | 0.65 |
| NEURODEGENERATION | causes | disease | 0.65 |
| TNF | inhibits | gene | 0.65 |
| NEURONS | activates | cell_type | 0.65 |
| INFLAMMATION | activates | phenotype | 0.65 |
| TNF | treats | gene | 0.65 |
| TAU | depleted_in | protein | 0.55 |
| NEUROINFLAMMATION | implicated_in | phenotype | 0.55 |
| STRIATUM | associated_with | brain_region | 0.50 |
| WHITE MATTER | associated_with | brain_region | 0.45 |
| ETANERCEPT | associated_with | drug | 0.45 |
| MEDULLA OBLONGATA | associated_with | brain_region | 0.45 |
| DNA DAMAGE RESPONSE | associated_with | pathway | 0.45 |
| NEUROFILAMENT LIGHT | associated_with | biomarker | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| RIPK1 | mediates | protein | 0.95 |
| DRP1 | mediates | protein | 0.92 |
| Mitochondrial Defects | causes | phenotype | 0.92 |
| RIPK3 | mediates | protein | 0.90 |
| Resveratrol | protects_against | compound | 0.90 |
| OPTN | protects_against | gene | 0.90 |
| SARM1 | associated_with | gene | 0.90 |
| 34326423 | is associated with | paper | 0.90 |
| Mrna Transport | associated_with | process | 0.90 |
| SOD1 | associated_with | gene | 0.88 |
| MFN2 Mutations | contributes_to | biomarker | 0.88 |
| Necroptosis | causes | process | 0.85 |
| Necroptosis | associated_with | process | 0.85 |
| TP53 | causes | gene | 0.85 |
| Multiple Sclerosis | causes | disease | 0.85 |
| POLY(GLYCINE-ARGININE) | causes | protein | 0.82 |
| small-molecule modulators of axonal degeneration | suppresses | drug | 0.75 |
| NEURONS | protects_against | cell_type | 0.70 |
| IFN | causes | gene | 0.70 |
| α-Synuclein | activates | protein | 0.70 |
| etanercept | protects_against | drug | 0.70 |
| GAN | regulates | gene | 0.70 |
| SARM1 | activates | protein | 0.70 |
| TARDBP | regulates | gene | 0.70 |
| TARDBP | treats | gene | 0.70 |
| mitochondrial defects | activates | process | 0.70 |
| TBK1 | causes | gene | 0.65 |
| PARP1 | causes | gene | 0.65 |
| SIRT1 | exacerbates | gene | 0.65 |
| DEMENTIA | degrades | disease | 0.65 |
| MLKL | protects_against | gene | 0.65 |
| OXIDATIVE STRESS | regulates | phenotype | 0.65 |
| HDAC6 | inhibits | gene | 0.65 |
| HDAC6 | treats | gene | 0.65 |
| EXCITOTOXICITY | activates | phenotype | 0.65 |
| OLIGODENDROCYTES | causes | cell_type | 0.65 |
| ALS | treats | disease | 0.65 |
| OPTN | causes | gene | 0.65 |
| RIPK3 | regulates | gene | 0.65 |
| RIPK1 | regulates | gene | 0.65 |
| FGF2 | interacts_with | gene | 0.65 |
| 33440165 | causes | paper | 0.60 |
| NECROPTOSIS | implicated_in | phenotype | 0.55 |
| NECROPTOSIS | participates_in | phenotype | 0.55 |
| GFAP | associated_with | gene | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Stathmin-2 Splice Switching to Prevent Axonal Degeneration A | 0.664 | neurodegeneration | RNA binding protein dysregulation across |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning AXONAL DEGENERATION in their description or question text
No additional research found